https://www.selleckchem.com/pr....oducts/Bafetinib.htm
If not reversible, this process could lead to a dramatic increase in disability and unsustainable social costs for many Governments.We report our experience during COVID-19 outbreak for intravitreal injections in patients with maculopathy. We proposed a treatment priority levels and timings; the "High" priority level includes all monocular patients; the "Moderate" is assigned to all patients with an active macular neovascularization; the patients affected by diabetic macular edema or retinal vein occlusion belong to the "Low" class. T
Like
Comment
Share
